Medication (when prescribed) is included in the cost of the DirectMeds program
Month 1: 0.5 mg, once daily Month 2: 1 mg, once daily Month 3: 1.5 mg, once daily Month 4: 2 mg, once daily Month 5 and beyond (maintenance): 2.5 mg, once daily Medication is prescribed only after consultation with a licensed provider to determine appropriateness
These secondary indications sometimes face less prior authorization friction than the primary weight-loss indication
Plenity Plenity isn't a drug it's sold as a medical device
Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies
All currently available GLP-1 medications carry the same boxed warning regarding thyroid C-cell tumors based on animal studies, and none have demonstrated superiority or increased risk specifically in patients with autoimmune thyroid disease